News
Featured
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed that of all previous years. The WGND is tracking 19 drug candidates that have initiated or completed a Phase 1 clinical trial for use in treating Tuberculosis. Most have been or are currently being evaluated in a Phase 2 clinical trial and one has made it to Phase 3. These 19 do...
News
1 Jul 2010
Published by the WHO here: http://www.searo.who.int/en/Section10/Section2097/Section2106_10681.htm An online mini-series on TB and children is viewable here: http://stoptb.citizen-news.org/2010/07/online-discussion-mini-series-tb-and.html Over 250,000 children develop TB and 100,000 children will...
1 Jul 2010
Aeras Global TB Vaccine Foundation Announces Appointment of Accomplished Pharmaceutical Executive as President and CEO James E. Connolly Committed to Accelerating the Development of New Vaccines to Prevent Tuberculosis Rockville, Maryland, July 1, 2010 — The Aeras Global TB Vaccine Foundation today...
30 Jun 2010
The Diagnosis Dilemma: How Could They Treat It If They Didn’t Know What It Was? Until the discovery of the antibiotic streptomycin in 1944, sufferers of tuberculosis and their physicians throughout recorded history did not know that the diverse collection of maladies and symptoms they fought were...
29 Jun 2010
This article originally appeared in the American Journal of Nursing here: http://journals.lww.com/ajnonline/Fulltext/2010/07000/The_War_on_Tuberculosis.14.aspx Haile Meskel emerges from his Newark, New Jersey, row house and slips into the passenger seat of a shiny, late-model sedan, where a woman...
28 Jun 2010
A biochip assay- an example of a diagnostic test based on disease biomarkers By far, one of the greatest needs in TB R&D is the identification of biomarkers. The value of biomarkers cannot be overemphasized. Briefly, we will highlight what biomarkers are, how they are used, and describe their...
27 Jun 2010
photo courtesy LA County Supervisor Zev Yaroslavsky's blog This post originally appeared on the website of LA County Supervisor Zev Yaroslavsky: http://zev.lacounty.gov/news/health/future-of-olive-view-tb-ward-in-doubt Los Angeles County is spending more than $16 million to build a dedicated...
21 Jun 2010
Analysis of PDP Funding Landscape released by G-FINDER Last week, an analysis of product development partnerships (PDP) funding based on data from G-FINDER was published in the journal, International Health . The article praises successful PDPs as productive and cost-effective, while calling...
17 Jun 2010
Bethesda Sanatorium 1920; Photo by Louis Charles McClure, 1867-1957, www.hellodenver.com/Photos_People.Cfm What do wolf’s liver, the touch of a king and millipede syrup have in common? These were all early treatments for tuberculosis before the advent of the TB hospitals called sanatoriums and then...
16 Jun 2010
from The New York Times In Florida, a Lifeline to Patients With TB By DAMIEN CAVE LANTANA, Fla. — The last of the nation’s original tuberculosis sanitariums sits, improbably, just off Interstate 95, near a Dunkin’ Donuts and a Motel 6, and just behind fields of children playing soccer. The fading...
14 Jun 2010
Johns Hopkins Medicine On Friday, June 11 th , the Johns Hopkins University Center for Tuberculosis Research hosted their annual scientific meeting and the WGND was there to cover the event. Approximately 100-200 people were present including persons from NIH and small pharmaceutical companies...
9 Jun 2010
ACTION presents Health SWAPS in Sub-Saharan Africa: Delivering on the Promise? Moderated by Robert Hecht Managing Director, Results for Development Institute Wednesday, June 16, 2010 7:00pm–9:00pm *Food and drinks will be served* at the Omni Shoreham Hotel (Capitol Room) 2500 Calvert Street...
7 Jun 2010
The TB Pipeline starts here! Our goal is to keep our audience up to date on the latest TB drug research & development. The past couple of months have seen a flurry of publishing activity. In order to present these to you quickly, we are diverging from our usual one-by-one analysis in favor of...
3 Jun 2010
To sign on to this letter, please email your name or the name of your organization to Lucy Cheshire at lucy_chesire@yahoo.com . Dear UNITAID Executive Board, We write as members of civil society to draw attention to a grave and urgent situation – the unexplainable delay of board approved grants to...
2 Jun 2010
Clinical Research Scientist for the TB Alliance This video was recorded on November 13, 2009 at Johns Hopkins University. Dr. Martino Laurenzi Dr. Laurenzi, an expert in clinical development and community health, is a Clinical Research Scientist at the TB Alliance, where his responsibilities...
31 May 2010
credit: Mary O'Reilly Science Illustration By Gerry Waters, Senior Director, Biology at the TB Alliance A team of researchers led by Rainer Kalscheuer and Bill Jacobs at the Albert Einstein College of Medicine in New York recently published a paper titled “Self-poisoning of M. tuberculosis by...
